4//SEC Filing
Emerald Health Sciences Inc. 4
Accession 0001209191-18-056825
CIK 0001516551other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 6:45 PM ET
Size
9.3 KB
Accession
0001209191-18-056825
Insider Transaction Report
Form 4
Emerald Health Sciences Inc.
10% Owner
Transactions
- Other
7% Convertible Debt
2018-11-01Exercise: $0.40→ Common Stock (5,000,000 underlying) - Other
Warrant (Right to Buy)
2018-11-01+2,500,000→ 2,500,000 totalExercise: $0.50→ Common Stock (2,500,000 underlying)
Footnotes (3)
- [F1]Represents an advance of $2,000,000 (the "Advance") made by the Reporting Person to the Issuer pursuant to a Multi-Draw Credit Agreement, between the Issuer and the Reporting Person (the "Agreement"). The Advance is convertible into shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), at the Reporting Person's option, in whole or in part, at any time after issuance. The conversion price of $.40 per share of Common Stock will be subject to adjustment for stock dividends, stock splits, dilutive securities issuances and other customary adjustment events. The maturity date is the earlier of (a) October 5, 2022 and (b) the date on which all amounts under the Agreement shall become due and payable.
- [F2]The common stock purchase warrant (the "Warrant") was issued to the reporting person in connection with the Advance pursuant to the Agreement. The Warrant is exercisable at the Reporting Person's option, in whole or in part, at any time after issuance. The expiration date is 5 years from the issuance of the Warrant. The Warrant shall continue to be exercisable notwithstanding the repayment in full of the Advance.
- [F3]Represents 50% of the number of shares issuable upon conversion of the Advance.
Documents
Issuer
Nemus Bioscience, Inc.
CIK 0001516551
Entity typeother
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001728413
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 6:45 PM ET
- Size
- 9.3 KB